Resultados de la búsqueda 571-580 of 4265 for Relapse
... relapse, and subsequent therapy. A Study to Evaluate the Immune Response to Anti-HER2 Therapies. Jacksonville, Fla. The purpose of this study is to determine ...
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
The purpose of this study is to evaluate the clinical outcomes of the Micropulse Trans-Scleral Cyclophotocoagulation Laser (MPTSCPC) after 1 day, ...
... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ... Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Blood ...
... Relapsed Or Refractory Chronic Lymphocytic Leukemia. Rochester, Minn. This study will assess the safety, tolerability, pharmaokinetics, and preliminary ...
Metastatic Tumor Research and Outcomes Network ... Rochester, Minn. The registry aims to collect patient information such as patient demographics, co-morbidities, ...
Rochester, Minn. The purpose of this study is to determine the time from intramuscular injection to the time of first fetal movement after a fetal surgery ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
... Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL). Rochester ... Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). A Study ...
De Mayo Clinic a tu buzón. Inscríbete gratis y mantente al día en cuanto a avances en las investigaciones, consejos sobre salud, temas médicos de actualidad ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?